These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22820139)
1. Clinical significance of suppressor of cytokines signalling-3 mRNA expression from patients with non-Hodgkin lymphoma under chemotherapy. Attia FM; Hassan AM; El-Maraghy NN; Ibrahium GH Cancer Biomark; 2011-2012; 11(1):41-7. PubMed ID: 22820139 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of SOCS3 in monocytes and SOCS1 in lymphocytes correlates with progressive loss of renal function and cardiovascular risk factors in chronic kidney disease. Rastmanesh MM; Bluyssen HA; Joles JA; Boer P; Willekes N; Braam B Eur J Pharmacol; 2008 Sep; 593(1-3):99-104. PubMed ID: 18656467 [TBL] [Abstract][Full Text] [Related]
3. Increased SOCS expression in peripheral blood mononuclear cells of end stage renal disease patients is related to inflammation and dialysis modality. Rastmanesh MM; Braam B; Joles JA; Boer P; Bluyssen HA Eur J Pharmacol; 2009 Jan; 602(1):163-7. PubMed ID: 19041303 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value. Uskudar Teke H; Gulbas Z; Bal C J BUON; 2014; 19(1):191-7. PubMed ID: 24659663 [TBL] [Abstract][Full Text] [Related]
5. Expression of suppressor of cytokine signaling 1 in the peripheral blood of patients with idiopathic pulmonary fibrosis. Bao Z; Zhang Q; Wan H; He P; Zhou X; Zhou M Chin Med J (Engl); 2014; 127(11):2117-20. PubMed ID: 24890164 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of some inflammatory markers in patients with lymphoma. Hamed Anber N; El-Sebaie AH; Darwish NHE; Mousa SA; Shamaa SS Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30814315 [No Abstract] [Full Text] [Related]
7. The expression of SOCS is altered in rheumatoid arthritis. Isomäki P; Alanärä T; Isohanni P; Lagerstedt A; Korpela M; Moilanen T; Visakorpi T; Silvennoinen O Rheumatology (Oxford); 2007 Oct; 46(10):1538-46. PubMed ID: 17726036 [TBL] [Abstract][Full Text] [Related]
8. Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype. Edlefsen KL; Martínez-Maza O; Madeleine MM; Magpantay L; Mirick DK; Kopecky KJ; LaCroix AZ; De Roos AJ Int J Cancer; 2014 Aug; 135(4):913-22. PubMed ID: 24488825 [TBL] [Abstract][Full Text] [Related]
9. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis? Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869 [TBL] [Abstract][Full Text] [Related]
10. The Correlation Between Non-Hodgkin Lymphoma and Expression Levels of B-Cell Activating Factor and Its Receptors. Shen X; Wang M; Guo Y; Ju S Adv Clin Exp Med; 2016; 25(5):837-844. PubMed ID: 28028945 [TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. Santangelo C; Scipioni A; Marselli L; Marchetti P; Dotta F Eur J Endocrinol; 2005 Mar; 152(3):485-9. PubMed ID: 15757867 [TBL] [Abstract][Full Text] [Related]
12. [Association between suppressors of cytokine signaling mRNA expression and Th1/Th2 balance in children with asthma]. Hui Y; Xie JJ; Li L; Xiang HX; Mu HJ; Yin Y; Zhang XJ Zhongguo Dang Dai Er Ke Za Zhi; 2012 Oct; 14(10):755-8. PubMed ID: 23092567 [TBL] [Abstract][Full Text] [Related]
13. [Serum tumor necrosis factor-alpha levels in non-Hodgkin's lymphoma patients and its relationship to prognosis]. Li D; Li G; Wang B Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):293-6. PubMed ID: 11038763 [TBL] [Abstract][Full Text] [Related]
14. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma. Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931 [TBL] [Abstract][Full Text] [Related]
15. Detection of circulating lymphoma cells in patients with non-Hodgkin lymphoma using MAGE-A3 gene expression in peripheral blood. Han MH; Eom HS; Park WS; Yun T; Park S; Kim HJ; Jeon CH; Kong SY Leuk Res; 2010 Sep; 34(9):1127-31. PubMed ID: 20036422 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma. Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892 [TBL] [Abstract][Full Text] [Related]
17. Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma. Zidan J; Hussein O; Basher W; Zohar S Oncologist; 2004; 9(4):417-21. PubMed ID: 15266095 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between the expression of murine double minute 2 oncogene and non-Hodgkin lymphoma in childhood]. Liu Z; Long GF; Han YL; Wei HY Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):928-31. PubMed ID: 15733365 [TBL] [Abstract][Full Text] [Related]
19. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease]. Liu YX; Wang H; Peng XY; Zhou ZC Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421 [TBL] [Abstract][Full Text] [Related]
20. [Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma]. Zhang DS; Jiang WQ; Li S; Zhang XS; Mao H; Chen XQ; Li YH; Zhan J; Wang FH Ai Zheng; 2003 Aug; 22(8):870-3. PubMed ID: 12917038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]